In the last trading session, 59654.0 shares of the TherapeuticsMD Inc (NASDAQ:TXMD) were traded, and its beta was 1.19. Most recently the company’s share price was $1.06, and it changed around $0.02 or 1.92% from the last close, which brings the market valuation of the company to $12.22M. TXMD currently trades at a discount to its 52-week high of $2.75, offering almost -159.43% off that amount. The share price’s 52-week low was $0.70, which indicates that the current value has risen by an impressive 33.96% since then. We note from TherapeuticsMD Inc’s average daily trading volume that its 10-day average is 0.91 million shares, with the 3-month average coming to 292.82K.
TherapeuticsMD Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 1 recommended TXMD as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
TherapeuticsMD Inc (NASDAQ:TXMD) trade information
Instantly TXMD has showed a green trend with a performance of 1.92% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.1391 on recent trading dayincreased the stock’s daily price by 6.94%. The company’s shares are currently up 23.26% year-to-date, but still down -3.64% over the last five days. On the other hand, TherapeuticsMD Inc (NASDAQ:TXMD) is -10.17% down in the 30-day period. We can see from the shorts that 11980.0 shares have been sold at a short interest cover period of 0.23 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 49.33%.
TXMD Dividends
TherapeuticsMD Inc’s next quarterly earnings report is expected to be released in February.
TherapeuticsMD Inc (NASDAQ:TXMD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.71% of TherapeuticsMD Inc shares, and 44.53% of them are in the hands of institutional investors. The stock currently has a share float of 45.30%. TherapeuticsMD Inc stock is held by 43.0 institutions, with RUBRIC CAPITAL MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 10.3381% of the shares, which is about 1.19 million shares worth $1.92 million.
CLEARLINE CAPITAL LP, with 5.5205% or 0.64 million shares worth $1.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
